Additionally, molecular docking studies have demonstrated that Cordycepin can effectively bind to P53 and P21 proteins, supporting its potential mechanism of action in treating PAH (Fig. 11)37. The gene discussed is TP53; the disease is pulmonary arterial hypertension.